WeLoveDoctor

Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors

Written by

byun1114

in

이전에 소개한 논문에서 추가를 해야할 것인가..

뭔 이 사람들은 계속 발표를 하는지…

2013/04/16 – [공부해 봅시다/Pathology] – Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Reference: Leighl, N.B., et al., Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline. J Clin Oncol, 2014.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts